CN109963875A - 靶向并通过辐射能分解癌症的癌症结合不透射线肽类 - Google Patents

靶向并通过辐射能分解癌症的癌症结合不透射线肽类 Download PDF

Info

Publication number
CN109963875A
CN109963875A CN201780071482.1A CN201780071482A CN109963875A CN 109963875 A CN109963875 A CN 109963875A CN 201780071482 A CN201780071482 A CN 201780071482A CN 109963875 A CN109963875 A CN 109963875A
Authority
CN
China
Prior art keywords
radiopaque
peptides
cancer
compound
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201780071482.1A
Other languages
English (en)
Chinese (zh)
Inventor
史蒂文·D·延森
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cao Group Inc
Original Assignee
Cao Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cao Group Inc filed Critical Cao Group Inc
Publication of CN109963875A publication Critical patent/CN109963875A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/40—Arrangements for generating radiation specially adapted for radiation diagnosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/6435—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the peptide or protein in the drug conjugate being a connective tissue peptide, e.g. collagen, fibronectin or gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0461—Dispersions, colloids, emulsions or suspensions
    • A61K49/0466—Liposomes, lipoprotein vesicles, e.g. HDL or LDL lipoproteins, phospholipidic or polymeric micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/48—Diagnostic techniques
    • A61B6/481—Diagnostic techniques involving the use of contrast agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Radiology & Medical Imaging (AREA)
  • Surgery (AREA)
  • Optics & Photonics (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
CN201780071482.1A 2016-10-26 2017-10-25 靶向并通过辐射能分解癌症的癌症结合不透射线肽类 Pending CN109963875A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662412945P 2016-10-26 2016-10-26
US62/412,945 2016-10-26
PCT/US2017/058269 WO2018081256A1 (en) 2016-10-26 2017-10-25 Cancer binding radio-opaque peptides that are targeted for disintegration by radiant energy

Publications (1)

Publication Number Publication Date
CN109963875A true CN109963875A (zh) 2019-07-02

Family

ID=62023998

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201780071482.1A Pending CN109963875A (zh) 2016-10-26 2017-10-25 靶向并通过辐射能分解癌症的癌症结合不透射线肽类

Country Status (4)

Country Link
US (1) US20190274645A1 (enExample)
JP (1) JP2019534285A (enExample)
CN (1) CN109963875A (enExample)
WO (1) WO2018081256A1 (enExample)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110182814A1 (en) * 2008-04-14 2011-07-28 Kimberly Kelly Plectin-1 targeted agents for detection and treatment of pancreatic ductal adenocarcinoma
US20120269721A1 (en) * 2009-10-12 2012-10-25 The Regents Of The University Of California Targeted nanoclusters and methods of their use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7541440B2 (en) * 2002-09-30 2009-06-02 Immunomedics, Inc. Chimeric, human and humanized anti-granulocyte antibodies and methods of use
US20080058785A1 (en) * 2006-04-12 2008-03-06 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Autofluorescent imaging and target ablation
US20100183504A1 (en) * 2007-06-14 2010-07-22 Fanqing Frank Chen Multimodal imaging probes for in vivo targeted and non-targeted imaging and therapeutics
US8524239B2 (en) * 2010-07-09 2013-09-03 The United States of America as represented by the Secrectary, Department of Health and Human Services Photosensitizing antibody-fluorophore conjugates

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110182814A1 (en) * 2008-04-14 2011-07-28 Kimberly Kelly Plectin-1 targeted agents for detection and treatment of pancreatic ductal adenocarcinoma
US20120269721A1 (en) * 2009-10-12 2012-10-25 The Regents Of The University Of California Targeted nanoclusters and methods of their use

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BARROTT J J ET AL.: "Optical and radioiodinated tethered Hsp90 inhibitors reveal selective internalization of ectopic Hsp90 in malignant breast tumor cells", 《CHEMISTRY & BIOLOGY》 *

Also Published As

Publication number Publication date
JP2019534285A (ja) 2019-11-28
US20190274645A1 (en) 2019-09-12
WO2018081256A1 (en) 2018-05-03

Similar Documents

Publication Publication Date Title
AU2010201870B2 (en) Method and Device for Radiotherapy
Thomas et al. Intraoperative high‐dose rate interstitial irradiation of hepatic metastases from colorectal carcinoma. Results of a phase I–II trial
KR20170015570A (ko) 세포 증식 질환을 치료하기 위한 방법 및 시스템
JP2002534218A (ja) 非侵襲性の脈管療法
KR20250133984A (ko) 세포-대-세포 통신을 측정 및 유도하기 위한 방법, 장치 및 조성물, 및 이의 치료적 용도
JP2015178002A (ja) 手術時イメージングまたはセンチネルリンパ節バイオプシー用の発光ダイ
AU2007217090A1 (en) Methods and systems for delivering radiation therapy to treat disorders in patients
Heger et al. Can local ablative techniques replace surgery for locally advanced pancreatic cancer?
CN109963875A (zh) 靶向并通过辐射能分解癌症的癌症结合不透射线肽类
WO2019244977A1 (ja) 腫瘍治療法
CN109963874A (zh) 靶向并通过辐射能分解癌症的癌症结合着色肽
Saidi et al. Nonthermal ablation of malignant esophageal strictures: photodynamic therapy, endoscopic intratumoral injections, and novel modalities
Nishioka Applications of lasers in gastroenterology
AKAKURA et al. The combined treatment for carcinoma of the esophagus with the radical resection and the preoperative irradiation
Maciel et al. Nd-YAG laser as a palliative treatment for malignant dysphagia
Pritikin et al. Endoscopic laser therapy in gastroenterology
Obarski et al. Esophageal Lumen Restoration
JP2024152963A (ja) Ｐｄо線加熱式癌細胞死滅治療法ｐｄ３６
Mols et al. Laser-induced thermotherapy (LITT): dose-effect relation on lung tissue
WO2007149951A2 (en) Systems and methods for use of luminescent compounds in disease treatment and medical imaging
Carrara et al. EUS-Assisted Ablation Techniques
AU2004233763B2 (en) Method and device for radiotherapy
Nasir A REVIEW OF THE USES OF LASER IN GASTRO-INTESTINAL TRACT
Momchilov et al. Development of low-cost photodynamic therapy device
Brunetaud et al. Lasers in digestive endoscopy

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20190702

WD01 Invention patent application deemed withdrawn after publication